AZZAD ASSET MANAGEMENT INC /ADV

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1121914 FALLS CHURCH, VA

Position in REGN

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$613,563

-$144,396 QoQ

Shares Held

984

+0.3% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#755

of 1,322 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

AZZAD ASSET MANAGEMENT INC /ADV holds $5,807,017 across 7 Biotechnology names. REGN ranks #5 (10.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	4,630	$1,393,768
2	INCY	Incyte Corp	9,067	$1,027,835
3	TECH	BIO-TECHNE Corp	14,008	$989,665
4	HALO	Halozyme Therapeutics, Inc.	12,424	$972,426
5	REGN	Regeneron Pharmaceuticals, Inc. This page	984	$613,563
6	EXEL	Exelixis, Inc.	7,911	$430,437
7	IONS	Ionis Pharmaceuticals Inc	4,784	$379,323

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$613,563	984	+0.3%	Shares	Sole	2026-07-29
2026-03-31	$757,959	981	-68.3%	Shares	Sole	2026-04-30
2022-09-30	$2,130,674	3,093	-39.3%	Shares	Sole	2024-04-01
2022-06-30	$3,010,625	5,093	+100.7%	Shares	Sole	2024-04-01
2022-03-31	$1,772,589	2,538	-23.7%	Shares	Sole	2024-04-01
2021-12-31	$2,101,067	3,327	+1.0%	Shares	Sole	2024-04-01
2021-09-30	$1,994,068	3,295	+2.3%	Shares	Sole	2024-04-01
2021-06-30	$1,799,057	3,221	-3.0%	Shares	Sole	2024-04-01
2021-03-31	$1,571,297	3,321	+7.5%	Shares	Sole	2024-04-01
2020-12-31	$1,491,843	3,088	-0.1%	Shares	Sole	2024-04-01
2020-09-30	$1,730,279	3,091	+22.5%	Shares	Sole	2024-04-01
2020-06-30	$1,574,092	2,524	-18.8%	Shares	Sole	2024-04-01
2020-03-31	$1,517,117	3,107	—	Shares	Sole	2024-04-01
No filing history on record for this holder in this stock.